Pro Share Advisors LLC Abb Vie Inc. Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

A detailed history of Pro Share Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 1,283,596 shares of ABBV stock, worth $220 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

1,283,596

Previous 1,334,430 3.81%

Holding current value

$220 Million

Previous $207 Million 13.03%

% of portfolio

0.64%

Previous 0.64%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $8.12 Million - $9.26 Million	-50,834 Reduced 3.81%	1,283,596 $234 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $28 Million - $31.5 Million	-203,257 Reduced 13.22%	1,334,430 $207 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $25.7 Million - $29.8 Million	192,632 Added 14.32%	1,537,687 $229 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $13 Million - $16.2 Million	-98,385 Reduced 6.82%	1,345,055 $181 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $15.7 Million - $18 Million	108,304 Added 8.11%	1,443,440 $230 Million

Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $1.34 Million - $1.61 Million	9,677 Added 0.73%	1,335,136 $216 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $3.63 Million - $4.17 Million	-27,073 Reduced 2.0%	1,325,459 $178 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $28.6 Million - $36.3 Million	-207,457 Reduced 13.3%	1,352,532 $207 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $25.3 Million - $31.4 Million	-191,538 Reduced 10.94%	1,559,989 $253 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $25.6 Million - $32.4 Million	238,062 Added 15.73%	1,751,527 $237 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $1.41 Million - $1.6 Million	13,266 Added 0.88%	1,513,465 $163 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $23.2 Million - $25.9 Million	220,847 Added 17.26%	1,500,199 $169 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $18.6 Million - $20.5 Million	-182,306 Reduced 12.47%	1,279,352 $138 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $21.8 Million - $29.4 Million	270,318 Added 22.69%	1,461,658 $157 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $1.11 Million - $1.3 Million	12,882 Added 1.09%	1,191,340 $104 Million
Q2 2020 Aug 03, 2020	SELL	$73.37 - $98.18 $15.9 Million - $21.3 Million	-216,761 Reduced 15.54%	1,178,458 $116 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $18.5 Million - $28 Million	-286,839 Reduced 17.05%	1,395,219 $106 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $1.09 Million - $1.37 Million	15,161 Added 0.91%	1,682,058 $149 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $22.2 Million - $26.6 Million	351,803 Added 26.75%	1,666,897 $126 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $13.1 Million - $16.8 Million	199,885 Added 17.92%	1,315,094 $95.6 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $2.21 Million - $2.6 Million	-28,621 Reduced 2.5%	1,115,209 $89.9 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $10.2 Million - $12.6 Million	130,976 Added 12.93%	1,143,830 $105 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $4.08 Million - $4.53 Million	45,870 Added 4.74%	1,012,854 $95.8 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $534,191 - $632,068	5,950 Added 0.62%	966,984 $89.6 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $5.16 Million - $6.9 Million	-56,042 Reduced 5.51%	961,034 $91 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $1.71 Million - $1.88 Million	-19,147 Reduced 1.85%	1,017,076 $98.4 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $6.04 Million - $7.71 Million	-86,463 Reduced 7.7%	1,036,223 $92.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,122,686	1,122,686 $81.4 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Abb Vie Inc. Transaction History